COMMUNIQUÉS West-GlobeNewswire

Clearmind Medicine Looks to Move Forward with its Novel Psychedelic MEAI- Based Alcohol Substitute

26/12/2024 - 12:59

Company recently signed a non-binding term sheet with Dr Glitter Pty Ltd for mutual development in ActivCrystal™ Format Vancouver, Canada, Dec. 26, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: [...]

SciSparc: AutoMax Announces $13 Million First Delivery of JAC Vehicles Following Regulatory Approval for Direct Importation

26/12/2024 - 12:46

TEL AVIV, Israel, Dec. 26, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), announced that AutoMax Motors Ltd., (“AutoMax”), a leading automotive importer and distributor in Israel with [...]

Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons

25/12/2024 - 17:40

Company announcement – No. 53 / 2024 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons Copenhagen, Denmark, [...]

Zealand Pharma major shareholder announcement: The Capital Group Companies, Inc.

25/12/2024 - 17:30

Company announcement – No. 52 / 2024 Zealand Pharma major shareholder announcement: The Capital Group Companies, Inc. Copenhagen, Denmark, 25 December 2024 – Zealand Pharma A/S (“Zealand”) (Nasdaq: ZEAL) (CVR-no. 20 04 [...]

CorVel Announces Effectiveness of Three-For-One Forward Stock Split

24/12/2024 - 19:15

FORT WORTH, Texas, Dec. 24, 2024 (GLOBE NEWSWIRE) -- CorVel Corporation (NASDAQ: CRVL) today announced the effectiveness of a three-for-one forward stock split, along with a proportionate increase in the number of [...]

Achilles Therapeutics Announces Sale of Technology Assets to AstraZeneca

24/12/2024 - 15:30

- Proprietary data and samples from TRACERx and Achilles’ Material Acquisition Platform (MAP) will be transferred to AstraZeneca under the Transaction - - Conclusion of Strategic Review - LONDON, Dec. 24, 2024 (GLOBE [...]

Trinity Biotech Announces Amended Credit Agreement with Perceptive to Enhance Liquidity and Drive Transformation Plan

24/12/2024 - 14:33

DUBLIN, Dec. 24, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today [...]

Carmell Announces PIPE Investment From Existing and New Investors To Support Commercial Build-out

24/12/2024 - 14:30

PITTSBURGH, Dec. 24, 2024 (GLOBE NEWSWIRE) -- Carmell Corporation (Nasdaq: CTCX), a bio-aesthetics company focused on skin and hair health (“Carmell”, the “Company”, “we”, “our”, or “us”), today announced that it [...]

LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock

24/12/2024 - 14:00

NEW YORK, Dec. 24, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that its Board of Directors has authorized a cash dividend to holders of the [...]

Clearmind Medicine Receives IRB Approval for its FDA-Regulated Clinical Trial

24/12/2024 - 12:55

Vancouver, Canada, Dec. 24, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel [...]

Patent Tech-AI Law NGO serving disabled people who can't afford attorney (Quantum computers meets law sector): VRN News

24/12/2024 - 11:21

P2P virtual law clinic aiding disabled veterans in legal actions may be the first AI-powered attorney network licensed in nearly every jurisdiction CAMBRIDGE, Mass., Dec. 24, 2024 (GLOBE NEWSWIRE) -- Earlier this month [...]

EssilorLuxottica: Déclaration de transactions sur actions propres

24/12/2024 - 08:00

Déclaration de transactions sur actions propres Paris, France (24 décembre 2024, 8h00) – Conformément à l’autorisation octroyée par l’Assemblée Générale du 30 avril 2024, EssilorLuxottica déclare que du 17 décembre 2024 [...]

Aster Guardians Global Nursing Award 2025 worth US$250,000 now open for nominations worldwide

24/12/2024 - 07:49

Registered nurses from across the world can submit their applications through www.asterguardians.com in their preferred languages by February 10, 2025 . DUBAI, United Arab Emirates, Dec. 24, 2024 (GLOBE NEWSWIRE) -- [...]

XBiotech suspend son programme de rhumatologie

24/12/2024 - 01:53

Des résultats de l’étude sur la polyarthrite rhumatoïde récemment conduite soulèvent des questions AUSTIN, Texas, 24 déc. 2024 (GLOBE NEWSWIRE) -- XBiotech (NASDAQ : XBIT) a annoncé aujourd’hui qu’elle suspendait son [...]

PolyPid Announces Positive Recommendation by DSMB to Continue Enrollment of Phase 3 SHIELD II Trial of D-PLEX₁₀₀ to 800 Patients with a Concurrent Private Placement of up to $41 Million

24/12/2024 - 01:22

• 630 Patients Enrolled To Date; Enrollment Completion Now Expected in Q1 2025 with Top-line Results Anticipated in Q2 2025; • Upon Potential Positive Phase 3 Data the Company Expects to Submit a New Drug Application (“ [...]

Neuphoria Completes Re-domiciliation and Successor Listing on Nasdaq

23/12/2024 - 22:49

BURLINGTON, Mass., Dec. 23, 2024 (GLOBE NEWSWIRE) -- Neuphoria Therapeutics Inc. (Nasdaq: NEUP) (“ Neuphoria ” or the “ Company ”) is pleased to announce that its previously announced scheme of arrangement in relation [...]

Teva to Present at the 43rd Annual J.P. Morgan Healthcare Conference

23/12/2024 - 22:30

TEL AVIV, Israel, Dec. 23, 2024 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Richard Francis, Teva's President and CEO, will present at the 43 rd Annual J.P. Morgan [...]

CVRx to Present at the 43rd Annual J.P. Morgan Healthcare Conference

23/12/2024 - 22:30

MINNEAPOLIS, Dec. 23, 2024 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company, today announced that the management team will present at the 43 rd Annual J.P. Morgan [...]

Solid Biosciences Added to the Nasdaq Biotechnology Index

23/12/2024 - 22:05

CHARLESTOWN, Mass., Dec. 23, 2024 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB) (the “Company” or “Solid”), a life sciences company developing precision genetic medicines for neuromuscular and cardiac [...]